182 related articles for article (PubMed ID: 35873795)
1. Inhibition of Xanthine Oxidase Protects against Sepsis-Induced Acute Kidney Injury by Ameliorating Renal Hypoxia.
Wang TT; Du YW; Wang W; Li XN; Liu HB
Oxid Med Cell Longev; 2022; 2022():4326695. PubMed ID: 35873795
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase, interleukin 1
Ibrahim YF; Fadl RR; Ibrahim S; Gayyed MF; Bayoumi A; Refaie M
Hum Exp Toxicol; 2020 Jul; 39(7):906-919. PubMed ID: 32054342
[TBL] [Abstract][Full Text] [Related]
3. Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK.
Nomura J; Busso N; Ives A; Tsujimoto S; Tamura M; So A; Yamanaka Y
PLoS One; 2013; 8(9):e75527. PubMed ID: 24086554
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.
Yang KJ; Kim JH; Chang YK; Park CW; Kim SY; Hong YA
Free Radic Biol Med; 2019 Dec; 145():209-220. PubMed ID: 31560952
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Xanthine Oxidase Protects against Diabetic Kidney Disease through the Amelioration of Oxidative Stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS Signaling Pathway.
Yang KJ; Choi WJ; Chang YK; Park CW; Kim SY; Hong YA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835220
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
Nambu H; Takada S; Maekawa S; Matsumoto J; Kakutani N; Furihata T; Shirakawa R; Katayama T; Nakajima T; Yamanashi K; Obata Y; Nakano I; Tsuda M; Saito A; Fukushima A; Yokota T; Nio-Kobayashi J; Yasui H; Higashikawa K; Kuge Y; Anzai T; Sabe H; Kinugawa S
Cardiovasc Res; 2021 Feb; 117(3):805-819. PubMed ID: 32402072
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Wang S; Li Y; Song X; Wang X; Zhao C; Chen A; Yang P
J Transl Med; 2015 Jul; 13():209. PubMed ID: 26136232
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation.
Sabán-Ruiz J; Alonso-Pacho A; Fabregate-Fuente M; de la Puerta González-Quevedo C
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):94-9. PubMed ID: 23286293
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress.
Tsuda H; Kawada N; Kaimori JY; Kitamura H; Moriyama T; Rakugi H; Takahara S; Isaka Y
Biochem Biophys Res Commun; 2012 Oct; 427(2):266-72. PubMed ID: 22995295
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor inhibits hypoxia/reoxygenation-induced activation of xanthine oxidase in endothelial cells through the JAK2 signaling pathway.
Zhang YQ; Hu SY; Chen YD; Guo MZ; Wang S
Int J Mol Med; 2016 Oct; 38(4):1055-62. PubMed ID: 27573711
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
Honorat JA; Kinoshita M; Okuno T; Takata K; Koda T; Tada S; Shirakura T; Fujimura H; Mochizuki H; Sakoda S; Nakatsuji Y
PLoS One; 2013; 8(8):e71329. PubMed ID: 23951137
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor suppresses hypoxia/reoxygenation-induced XO activation in cardiac microvascular endothelial cells.
Zhang Y; Hu S; Chen Y
Heart Vessels; 2015 Jul; 30(4):534-44. PubMed ID: 25062711
[TBL] [Abstract][Full Text] [Related]
13. MiR-150-5p protects against septic acute kidney injury via repressing the MEKK3/JNK pathway.
Shi L; Zhang Y; Xia Y; Li C; Song Z; Zhu J
Cell Signal; 2021 Oct; 86():110101. PubMed ID: 34333083
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase inhibitors and sepsis.
Ramos MFP; Monteiro de Barros ADCM; Razvickas CV; Borges FT; Schor N
Int J Immunopathol Pharmacol; 2018; 32():2058738418772210. PubMed ID: 29786457
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia.
Hartney T; Birari R; Venkataraman S; Villegas L; Martinez M; Black SM; Stenmark KR; Nozik-Grayck E
PLoS One; 2011; 6(11):e27531. PubMed ID: 22140445
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis.
Huang G; Bao J; Shao X; Zhou W; Wu B; Ni Z; Wang L
Life Sci; 2020 Aug; 254():117791. PubMed ID: 32416166
[TBL] [Abstract][Full Text] [Related]
17. [Scutellarin alleviates lipopolysaccharide-induced renal injury via mediating cysteine-rich protein 61-connective tissue growth factor-nephroblastoma overexpressed gene 1 expression to inhibit nuclear factor-κB signaling pathway].
Liu X; Qin Z; Guan C; Xu L; Dai J; Yang C; Zhou B; Luan H; Zhao L; Zhang W; Luo C; Xu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):400-406. PubMed ID: 35692206
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
[TBL] [Abstract][Full Text] [Related]
19. Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway.
Wang S; Zeng M; Li B; Kan Y; Zhang B; Zheng X; Feng W
Biomed Pharmacother; 2020 Sep; 129():110403. PubMed ID: 32574970
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K/Akt Signal Pathway.
Zhang BH; Liu H; Yuan Y; Weng XD; Du Y; Chen H; Chen ZY; Wang L; Liu XH
Drug Des Devel Ther; 2021; 15():4973-4983. PubMed ID: 34916780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
